Ankylosing Spondylitis Market By Drug Class (Non-Steroidal Anti-Inflammatory Drugs {Ibuprofen, Naproxen, Others}, Tumor Necrosis Factor (TNF) Inhibitors {Etanercept, Infliximab, Adalimumab, Golimumab}, Interleukin-17 (IL-17) Inhibitors {Secukinumab, Ixekizumab}, Disease-Modifying Antirheumatic Drugs {Methotrexate, Sulfasalazine}, Corticosteroids, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Hospitals, Specialty Clinics, Homecare), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Drug Class

• Non-Steroidal Anti-Inflammatory Drugs
  • Ibuprofen
  • Naproxen
  • Others
• Tumor Necrosis Factor (TNF) Inhibitors
  • Etanercept
  • Infliximab
  • Adalimumab
  • Golimumab
• Interleukin-17 (IL-17) Inhibitors
  • Secukinumab
  • Ixekizumab
• Disease-modifying antirheumatic Drugs
  • Methotrexate
  • Sulfasalazine
• Corticosteroids
• Others

 By Route of Administration

• Oral
• Injectable
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 By End-User

• Hospitals
• Specialty Clinics
• Homecare

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• AbbVie Inc.
• Amgen Inc.
• Pfizer Inc.
• Novartis AG
• Eli Lilly and Company
• UCB S.A.
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Boehringer Ingelheim
• Janssen Biotech, Inc.
• Gilead Sciences
• Zydus Cadila
• Hetero
• Izana Bioscience
• Reliance Life Sciences Pvt. Ltd.
• Celltrion Healthcare
• Pozen
• Iroko Pharmaceuticals